SkinHealth Systems Inc.
Close on Oct 19, 2026
- Market cap
- $1.37B
- P/E (TTM)
- –
- Dividend yield
- –
About SkinHealth Systems
Surgical & Medical Instruments & Apparatus, SIC 3841
The Beauty Health Company is a global medical aesthetics company focused on skin health solutions. Its core offering is Hydrafacial, a patented hydradermabrasion system that cleanses, exfoliates, extracts, and hydrates the skin using delivery devices alongside consumable treatment tips, solutions, and booster serums. The company also provides the HydraScalp system for scalp care and the SkinStylus microneedling and nano-channeling system for skin and scar treatments. The company serves providers across the professional medical market, such as dermatologists, plastic surgeons, and medical spas, as well as estheticians and beauty retail spas.
The company operates using a razor and razor blade model, distributing its capital equipment delivery systems and recurring consumables across North America, Europe, and Asia. It manufactures and assembles delivery systems at its facility in Long Beach, California, which also serves as a distribution hub alongside a global network of international fulfillment centers. Commercial distribution relies on both a direct sales force and third-party distributors across international markets.
Summary of the business section of SkinHealth Systems's latest annual report, written by StockData.
Company profile
Company
- Legal name
- SkinHealth Systems Inc.
- Headquarters
- Long Beach, CA
- Address
- 3600 E. Burnett Street 90815
- Phone
- (800) 603-4996
- Employees
- 613, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, Los Angeles, California
Stock & identifiers
- Ticker
- SKIN
- Exchange
- Nasdaq
- IPO date
- Sep 30, 2020
- Shares outstanding
- 130M, Aug 3, 2026
- Public float
- $158.40M, Jun 30, 2025
- Filer category
- Accelerated filer
- Stock splits
- 1-for-20 reverse, Oct 14, 2026
- SEC CIK
- 1818093
- CUSIP
- 88331L108
- ISIN
- US88331L1089
- LEI
- 5493001Z2JZQT4C63C50
- EIN
- 85-1908962
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Pedro Bruno Ferreira Malha | President and CEO, Director | 4,845,251 |
| Marla Malcolm Beck | President and CEO, Director | 2,753,401 |
| Michael P. Monahan | Chief Financial Officer | 1,955,280 |
| Sheri Lewis | CSO and COO | 1,584,620 |
| Ronald Menezes | Chief Revenue Officer | 1,759,915 |
| Kenneth Robert Tripp | Director | – |
| Edward Scott Beattie | Director | – |
| Sachin Mahavir Shridharani | Director | 1,500 |
| Philippe Schaison | Director | 57,692 |
| Brian Christopher Miller | Director | 33,603,776 |
| Stephen J. Fanning | Director | 527,283 |
| Brent L. Saunders | Director | 8,797,771 |
| Desiree Gruber | Director | 192,565 |
| Doug K. Schillinger | Director | 216,035 |
| Michelle C. Kerrick | Director | 189,813 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Andrew Stanleick | $0 | $0 | $2.31M | $11 | $142 |
| FY2025 Brenton LSaunders | $0 | $0 | $2.31M | $11 | $142 |
| FY2025 Clinton Carnell | $0 | $0 | $2.31M | $11 | $142 |
| FY2025 Marla Beck | $7.66M | $2.83M | $2.31M | $11 | $142 |
| FY2025 Pedro Malha | $6.31M | $5.54M | $2.31M | $11 | $142 |
| FY2024 Andrew Stanleick | $0 | $0 | $1.90M | $12 | $134 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we employed 613 employees, of whom approximately 80% were salaried, with the remainder being compensated on an hourly basis.”
Corporate history
Events identified from SEC filings